Current Price
KRWX is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for autoimmune diseases and cancer. Utilizing its proprietary drug discovery platform, the company is addressing critic...|
e.g. Promoter holding
Loading chart...
Analyst consensus EPS and Revenue forecasts.
Earnings estimates are not available for this company.
No peer comparison data available for this company.
Consolidated Figures in Millions / View Standalone.
| Quarter (M) |
|---|
Revenue |
COGS |
Gross Profit |
Gross Profit % |
EBIT |
OPM % |
Non-Operating Income |
PBT |
Income Tax |
Tax Rate % |
Net Income |
NPM % |
Consolidated Figures in Millions / View Standalone.
| Period (M) |
|---|
Revenue |
COGS |
Gross Profit |
Gross Profit % |
EBIT |
OPM % |
Non-Operating Income |
PBT |
Income Tax |
Tax Rate % |
Net Income |
NPM % |
Consolidated Figures in Millions / View Standalone.
| Period (M) |
|---|
Total Assets |
Total Liabilities |
Consolidated Figures in Millions / View Standalone.
| Period (M) |
|---|
Net CFNet Cash Flow |
FCFFree Cash Flow |
Financial ratios and valuation metrics by fiscal year.
| Period |
|---|
Cash Conversion |
Payout Ratio |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Who owns Corgi South Korea 2x Daily, from SEC filings
No SEC ownership filings for this company yet.
Corgi South Korea 2x Daily's SEC filings and earnings call transcripts
No SEC filings for this company yet.
What recent news says about Corgi South Korea 2x Daily, scored for sentiment.